Substituted pyrimidine compounds and their use as SYK inhibitors
US8871778B2 · kind B2 · utility
4Cited by
2References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 18, 2013 |
| Grant date | Oct 28, 2014 |
| Priority date | — |
| Expiry date | Jan 18, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of Formula (I) and methods for inhibiting kinases, including spleen tyrosine kinases, are disclosed. Also disclosed are methods for treating a kinase-mediated disease or condition by administering to a subject a therapeutically effective amount of the compound of Formula (I).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.